7
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Mapping drug biology to disease genetics to discover drug impacts on the human phenome

      research-article
      , ,
      Bioinformatics Advances
      Oxford University Press

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Motivation

          Medications can have unexpected effects on disease, including not only harmful drug side effects, but also beneficial drug repurposing. These effects on disease may result from hidden influences of drugs on disease gene networks. Then, discovering how biological effects of drugs relate to disease biology can both provide insight into the mechanism of latent drug effects, and can help predict new effects.

          Results

          Here, we develop Draphnet, a model that integrates molecular data on 429 drugs and gene associations of nearly 200 common phenotypes to learn a network that explains drug effects on disease in terms of these molecular signals. We present evidence that our method can both predict drug effects, and can provide insight into the biology of unexpected drug effects on disease. Using Draphnet to map a drug’s known molecular effects to downstream effects on the disease genome, we put forward disease genes impacted by drugs, and we suggest a new grouping of drugs based on shared effects on the disease genome. Our approach has multiple applications, including predicting drug uses and learning drug biology, with implications for personalized medicine.

          Availability and implementation

          Code to reproduce the analysis is available at https://github.com/RDMelamed/drug-phenome

          Related collections

          Most cited references48

          • Record: found
          • Abstract: not found
          • Article: not found

          Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles

            We previously piloted the concept of a Connectivity Map (CMap), whereby genes, drugs, and disease states are connected by virtue of common gene-expression signatures. Here, we report more than a 1,000-fold scale-up of the CMap as part of the NIH LINCS Consortium, made possible by a new, low-cost, high-throughput reduced representation expression profiling method that we term L1000. We show that L1000 is highly reproducible, comparable to RNA sequencing, and suitable for computational inference of the expression levels of 81% of non-measured transcripts. We further show that the expanded CMap can be used to discover mechanism of action of small molecules, functionally annotate genetic variants of disease genes, and inform clinical trials. The 1.3 million L1000 profiles described here, as well as tools for their analysis, are available at https://clue.io.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              The control of the false discovery rate in multiple testing under dependency

                Bookmark

                Author and article information

                Contributors
                Role: Formal analysisRole: InvestigationRole: MethodologyRole: Software
                Role: Data curationRole: InvestigationRole: Validation
                Role: Associate Editor
                Journal
                Bioinform Adv
                Bioinform Adv
                bioadv
                Bioinformatics Advances
                Oxford University Press
                2635-0041
                2024
                09 March 2024
                09 March 2024
                : 4
                : 1
                : vbae038
                Affiliations
                Department of Computer Science, University of Massachusetts Lowell , Lowell, MA 01854, United States
                Department of Biological Science, University of Massachusetts Lowell , Lowell, MA 01854, United States
                Department of Biological Science, University of Massachusetts Lowell , Lowell, MA 01854, United States
                Author notes
                Corresponding author. Department of Biological Science, University of Massachusetts Lowell, 198 Riverside St., Lowell, MA 01854, United States. E-mail: rachel_melamed@ 123456uml.edu
                Author information
                https://orcid.org/0000-0002-8245-1758
                https://orcid.org/0000-0003-3089-9806
                Article
                vbae038
                10.1093/bioadv/vbae038
                11087821
                38736684
                cd6eb9c0-d37b-4e98-9ce1-ae99e4869e5a
                © The Author(s) 2024. Published by Oxford University Press.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 30 October 2023
                : 18 January 2024
                : 17 February 2024
                : 07 March 2024
                : 11 April 2024
                Page count
                Pages: 12
                Funding
                Funded by: National Institutes of Health, DOI 10.13039/100000002;
                Award ID: K01ES028055
                Award ID: R35 GM151001-01
                Categories
                Original Article
                Disease Bioinformatics/Translational Medicine
                AcademicSubjects/SCI01060

                Comments

                Comment on this article